Cite
Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea
MLA
Massimiliano Bonifacio, et al. “Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea.” Blood, vol. 138, Nov. 2021, p. 2581. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........17955546cc4312651312ffa1323a63a4&authtype=sso&custid=ns315887.
APA
Massimiliano Bonifacio, Elena Maria Elli, Giuseppe Auteri, Giovanni Caocci, Daniela Bartoletti, Francesco Mendicino, Roberto Latagliata, Giulia Benevolo, Francesco Cavazzini, Novella Pugliese, Mario Tiribelli, Elena Rossi, Massimo Breccia, Monica Crugnola, Valerio De Stefano, Bruno Martino, Ambra Di Veroli, Francesca Palandri, Nicola Vianelli, … Gianni Binotto. (2021). Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea. Blood, 138, 2581.
Chicago
Massimiliano Bonifacio, Elena Maria Elli, Giuseppe Auteri, Giovanni Caocci, Daniela Bartoletti, Francesco Mendicino, Roberto Latagliata, et al. 2021. “Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea.” Blood 138 (November): 2581. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........17955546cc4312651312ffa1323a63a4&authtype=sso&custid=ns315887.